David Rescott

Stock Analyst at Baird

(3.38)
# 910
Out of 4,902 analysts
61
Total ratings
53.85%
Success rate
2.97%
Average return

Stocks Rated by David Rescott

Haemonetics
Jun 26, 2025
Initiates: Outperform
Price Target: $87
Current: $73.45
Upside: +18.45%
Medtronic
May 22, 2025
Maintains: Neutral
Price Target: $94$92
Current: $89.53
Upside: +2.76%
LivaNova
May 8, 2025
Maintains: Outperform
Price Target: $55$61
Current: $42.54
Upside: +43.39%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111$110
Current: $84.54
Upside: +30.12%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $315$330
Current: $230.10
Upside: +43.42%
Edwards Lifesciences
Apr 24, 2025
Maintains: Neutral
Price Target: $72$75
Current: $76.18
Upside: -1.55%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $115$120
Current: $104.65
Upside: +14.67%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600$575
Current: $516.16
Upside: +11.40%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25$26
Current: $16.75
Upside: +55.22%